Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001883850-23-000103)

Filing Details

Accession Number:: 0001883850-23-000103
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-26 16:08:29
Reporting Period:: 2023-12-21

Accepted Time:: 2023-12-26 16:08:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697422	R. Christopher Fenimore	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-21	456	$843.79	18,294	No	4	S	Direct
Common Stock	Disposition	2023-12-21	1,224	$844.09	17,070	No	4	S	Direct
Common Stock	Disposition	2023-12-22	250	$846.27	16,820	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,473	Indirect	2021 GRAT
Common Stock	4,269	Indirect	2022 GRAT
Common Stock	1,499	Indirect	By 401(k) Plan
Common Stock	1,897	Indirect	By Trust
Common Stock	461	Indirect	by Trust for Daugh
Common Stock	460	Indirect	by Trust for Son

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 25, 2023.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.